Page last updated: 2024-08-23

1-deoxynojirimycin and peptide yy

1-deoxynojirimycin has been researched along with peptide yy in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aerts, JM; Bijl, N; Bijland, S; Groen, AK; Houben-Weerts, JH; Houten, SM; Langeveld, M; Ottenhoff, R; Romijn, JA; van den Berg, SA; van Dijk, KW; van Roomen, CP; Voshol, PJ	1
Kaku, H; Tajiri, Y; Yamada, K	1
Aoki, K; Kamiko, K; Kamiyama, H; Masuda, K; Noguchi, Y; Tajima, K; Terauchi, Y	1

Trials

1 trial(s) available for 1-deoxynojirimycin and peptide yy

Article	Year
Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:4 Topics: 1-Deoxynojirimycin; Adult; Appetite; Appetite Depressants; Female; Gastric Emptying; Ghrelin; Glucagon-Like Peptide 1; Humans; Male; Obesity; Peptide YY; Young Adult	2012

Article

Year

Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:4

Topics: 1-Deoxynojirimycin; Adult; Appetite; Appetite Depressants; Female; Gastric Emptying; Ghrelin; Glucagon-Like Peptide 1; Humans; Male; Obesity; Peptide YY; Young Adult

2012

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and peptide yy

Article	Year
Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:1 Topics: 1-Deoxynojirimycin; Adamantane; Adipose Tissue; Animals; Body Weight; Carbohydrate Metabolism; Carnitine O-Palmitoyltransferase; Eating; Ghrelin; Glucose; Imino Sugars; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidation-Reduction; Peptide YY; Triglycerides; Up-Regulation; Weight Gain	2012
Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels. Endocrine journal, 2014, Volume: 61, Issue:3 Topics: 1-Deoxynojirimycin; Adamantane; Adult; Blood Glucose; Cholecystokinin; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Ghrelin; Humans; Insulin; Male; Middle Aged; Nitriles; Peptide YY; Pyrrolidines; Vildagliptin	2014

Article

Year

Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.

Metabolism: clinical and experimental, 2012, Volume: 61, Issue:1

Topics: 1-Deoxynojirimycin; Adamantane; Adipose Tissue; Animals; Body Weight; Carbohydrate Metabolism; Carnitine O-Palmitoyltransferase; Eating; Ghrelin; Glucose; Imino Sugars; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidation-Reduction; Peptide YY; Triglycerides; Up-Regulation; Weight Gain

2012

Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels.

Endocrine journal, 2014, Volume: 61, Issue:3

Topics: 1-Deoxynojirimycin; Adamantane; Adult; Blood Glucose; Cholecystokinin; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Ghrelin; Humans; Insulin; Male; Middle Aged; Nitriles; Peptide YY; Pyrrolidines; Vildagliptin

2014